Patient Guide: MEK Inhibitor Mirdametinib (PD-0325901) in Patients With Neurofibromatosis Type 1 Associated Plexiform Neurofibromas

We'll Help You Connect with This Trial

Quri.ai is a free clinical trial matching service. We help patients like you connect directly with research sites conducting this study.

  • Get matched to the right study location for you
  • Connect directly with study coordinators at 50 participating sites
  • Understand eligibility with our simplified screening tool
  • Free service - we're here to help you access clinical research
Trial ID: NCTNCT03962543
Status: ACTIVE_NOT_RECRUITING
Condition: Plexiform Neurofibroma, Neurofibromatosis Type 1 (NF1)
Phase: PHASE2

Find a Study Location Near You

This study is available at 50 research sites. We'll help you connect with the location that's right for you.

Participating sites include:
  • Birmingham, Alabama
  • Phoenix, Arizona
  • Little Rock, Arkansas
  • • And 47 more locations - let us help you find the closest one

Loading interactive enrollment tools...

The full interactive experience will load momentarily